Yuting Wang
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Discovery of a novel and potent KRASG12V-targeting peptide with antiproliferative activity against colorectal cancer cells.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: June 11, 2026
Screening of peptide inhibitors targeting YAP-TEAD4 interaction: affinity evaluation and anti-AML cell activity.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: March 09, 2026
Discovery of a Novel Dual-Targeting KRASG12D/HDAC Peptide Inhibitor for the Treatment of Pancreatic Cancer.
Journal: Journal of medicinal chemistry
Published: February 25, 2026
Discovery of novel and highly potent XIAP-targeted peptide inhibitors using virtual screening.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: January 22, 2026
Identification of a peptide inhibitor disrupting the PCSK9-LDLR interaction via pharmacophore-based virtual screening, molecular dynamics simulations and in vitro/vivo evaluation.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: January 22, 2026
Identification of novel HIF2α inhibitors: a structure-based virtual screening approach.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: January 06, 2026
Discovery of potent and highly selective sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for treating diabetic nephropathy.
Journal: Frontiers in pharmacology
Published: December 27, 2025
Identification of a novel and high-affinity cyclic peptide targeting Keap1 for inflammation treatment by a combined virtual screening strategy.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: November 06, 2025
Impact of the Fenton pretreatment on enhanced biological phosphorus removal: emphasizing variations in microbial community and metabolism.
Journal: Biodegradation
Published: October 28, 2025
Identification of a novel dual-targeting peptide inhibitor of SARS-CoV-2 RBD and NRP1 through structure-based virtual screening.
Journal: Frontiers in pharmacology
Published: August 24, 2025
Structure-based design of new potent and highly selective PARP-1 inhibitor for treating colorectal cancer.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: August 12, 2025
Discovery of novel and potent celastrol derivatives as PRDX1 inhibitors for cancer therapy through structure-based virtual screening.
Journal: Frontiers in pharmacology
Published: May 09, 2025
Last Updated: 09/26/2026